Literature DB >> 14624348

[Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma].

T Klotz1, F Hofstädter, M Gerken.   

Abstract

The primary intention of oncological follow-up for patients with bladder cancer is the early diagnosis of recurrent local tumors or metastatic disease. The question of subsequent independent tumors has not been assessed as very important. Data from the central cancer registry of Regensburg/Germany for the period 1990-1997 were examined to determine the risk of second primary cancers following an initial bladder cancer. Records of 921 males (mean age: 65.4 years) and 339 females (mean age: 68.0 years) with the primary diagnosis of bladder cancer were analyzed. The minimal follow-up has been 5 years. Bladder cancer patients experience an excess risk of subsequent independent malignancies. The ratio of observed cases to expected cases of subsequent tumors was increased. During the follow-up period, subsequent tumors have been found in 153 (16.6%) male patients and 35 (10.3%) female patients. The most common subsequent malignancies in males were prostate cancer (71 cases) and bronchial cancer (19 cases). Breast cancer (nine cases) and colon cancer were predominant in females. This confirms the good sense of regular oncological follow-up. In this context attention should be directed at tumors of non urological origin, and an interdisciplinary approach with an individual oncological follow-up seems to be useful. The focus should be on the prostate and lung for males and the breast and colon for females.

Entities:  

Mesh:

Year:  2003        PMID: 14624348     DOI: 10.1007/s00120-003-0396-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.

Authors:  Camilla Thellenberg; Beatrice Malmer; Björn Tavelin; Henrik Grönberg
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

2.  Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours.

Authors:  B Bittorf; H Kessler; S Merkel; W Brückl; A Wein; W G Ballhausen; W Hohenberger; K Günther
Journal:  Eur J Surg Oncol       Date:  2001-04       Impact factor: 4.424

3.  Multiple primary malignancies in association with soft tissue sarcomas.

Authors:  O Merimsky; Y Kollender; J Issakov; J Bickels; G Flusser; M Gutman; D Lev-Chelouche; M Inbar; I Meller
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

4.  Subsequent primary cancers following bladder cancer.

Authors:  E Salminen; E Pukkala; L Teppo; S Pyrhönen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  Second cancer following cancer of the urinary system in Denmark, 1943-80.

Authors:  O M Jensen; J B Knudsen; B L Sørensen
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

6.  Bladder cancer and the risk of smoking-related cancers during followup.

Authors:  E Salminen; E Pukkala; L Teppo
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

7.  [Clinical analysis of multiple primary cancers associated with bladder cancer].

Authors:  S Takahashi; M Sugimoto; M Shinohara; K Kinoshita
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1992-07

8.  Multiple primary malignancies in renal cell carcinoma.

Authors:  F Rabbani; G Grimaldi; P Russo
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

9.  Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.

Authors:  M McCredie; G J Macfarlane; J Stewart; M Coates
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

  9 in total
  2 in total

1.  Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.

Authors:  M J Mathers; J Zumbe; S Wyler; S Roth; M Gerken; F Hofstädter; T Klotz
Journal:  World J Urol       Date:  2008-04-18       Impact factor: 4.226

2.  Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population.

Authors:  Michael J Mathers; Stephan Roth; Monika Klinkhammer-Schalke; Michael Gerken; Ferdinand Hofstaedter; Stefan Wilm; Theodor Klotz
Journal:  J Cancer       Date:  2011-02-08       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.